Azienda Sanitaria Locale Citta Di Torino — Clinical Trial Site

16 Registered trials

3 Currently recruiting

Organisation

Azienda Sanitaria Locale Citta Di Torino

Location

Turin, Italy

Identifier

ORG-100043547

Address

Via San Secondo 29, 10128, Italy

Departments

Clinica Malattie Infettive
Clinica Universitaria di Malattie Infettive
Clinica Universitaria Malattie Infettive
Clinica Universitaria Malattie Infetttive
Clinical Unit of Infectious diseases
Department of Medical Sciences
Dipartimento di Scienze Mediche – Malattie infettive
Infectious Diseases
Neurologia e Stroke Unit
S.C. ENDOCRINOLOGIA E MALATTIE METABOLICHE
S.C. Oncologia
SCDU Nefrologia e Dialisi
SCDU Nefrologia e Dialisi - CMID

Clinical trials at this site (16)

Search interface

A clinical study of people with HIV-1 who received prior treatment combination of doravirine and islatravir Not authorised

2022-502126-40-00 HIV-1 infection 5
Study of Oral Weekly GS-1720 and GS-4182 Versus Biktarvy in People With HIV-1 Who Are Virologically Suppressed Pending

2024-511054-50-00 HIV-1 Infection 10
COLCOT-T2D Recruiting

2024-516646-19-00 Type 2 diabetic patients with no prior cardiovascular ( 5 2025-08-15
Pragmatic trial on the safety and tolerability of an optimized dose of rifampicin in tuberculosis patients Recruiting

2023-509885-39-00 Tuberculosis 5 2024-01-15
Efficacy and Safety of Tozorakimab in Patients Hospitalised for Viral Lung Infection Requiring Supplemental Oxygen (TILIA). Recruiting

2023-507031-38-00 Severe viral lung infections 5 2023-01-09
A Phase 2b Study Evaluating Oral VH4524184 Regimens in Treatment Naïve Persons with HIV-1 (INNOVATE Study) Ended

2025-521918-26-00 HIV Infections 4 2026-02-11
A Study to Evaluate Tobevibart+Elebsiran in Participants with Chronic HDV Infection Not Virologically Suppressed with Bulevirtide Ended

2024-519282-22-00 Chronic Hepatitis D Virus (HDV) Infection 5 2025-07-09
Efficacy of doravirine + dolutegravir dual therapy in the context of antiretroviral therapy switch Ended

2023-509751-14-03 HIV 4 2025-02-27
A Phase 2 Study of Obexelimab in Patients with Systemic Lupus Erythematosus Ended

2024-510584-37-00 Systemic Lupus Erythematosus 4 2024-10-22
A study to determine if ravulizumab can help preserve kidney function in adults with immunoglobulin A nephropathy (IgAN) Ended

2023-507851-31-00 Immunoglobulin A Nephropathy (IgAN) 5 2024-09-23
Evaluating efficacy and safety of switching a boosted protease inhibitor to fostemsavir in PLWH with limited therapeutic options (FOST Switc… Ended

2023-504192-25-00 HIV-1 6 2024-06-05
Study to Compare Bictegravir/Lenacapavir Versus Current Therapy in People With HIV-1 Who Are Successfully Treated With a Complicated Regimen Ended

2022-500929-33-01 Human Immunodeficiency Virus (HIV-1) infection 10 2023-05-17
Proof of concept treatment study of orally administered VH4004280 or VH4011499 in HIV-1 infected adults Ended

2023-505350-18-00 HIV Infections 4 2023-12-15
Ph 3b, BIC/FTC/TAF to DTG/3TC FDC, 96 Week switch, efficacy, safety, and tolerability study in ART-experienced older adults living with HIV … Ended

2022-503137-66-00 Human immunodeficiency virus (HIV) 5 2023-11-29
A study to test asundexian for preventing a stroke caused by a clot in participants after an acute ischemic stroke or after a high-risk tran… Ended

2023-503793-20-00 Prevention of ischemic stroke in patients post acute no 5 2023-01-18
Comparison of two strategies that use the same drugs but with inverted sequence for the treatment of patients with metastatic colorectal can… Ended

2024-513296-41-00 Colorectal cancer spread at distance, RAS BRAF wild typ 4 2020-12-03